相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

寻找有效的免疫疗法来对抗恶性外围神经膜瘤:有希望吗?

Siddhi N Paudel^1,2, Brian Hutzen¹, Timothy P Cripe^1,2,3,4

¹The Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA.

Molecular therapy oncolytics

|September 8, 2023

概括

免疫疗法对恶性外围神经膜瘤 (MPNSTs) 有希望,这是一个罕见的癌症,结果不佳. 研究正在探索基于免疫的策略和生物标志物,以改善MPNST患者的治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
肉瘤研究研究肉瘤研究

背景情况:

恶性外周神经膜瘤 (MPNSTs) 是一种罕见的软组织瘤,在手术后复发率高,对化疗反应不佳.
目前对MPNSTs的治疗选择有限,这突显了对新型治疗方法的需求.

研究的目的:

审查目前对MPNSTs免疫微环境的理解.
讨论针对MPNSTs新兴的基于免疫的治疗策略.
探索潜在的生物标志物来预测MPNST患者对免疫治疗的反应.

主要方法:

对MPNSTs和癌症免疫疗法的现有文献的审查.
分析免疫细胞透到MPNST中,包括巨细胞和T细胞.
讨论针对巨细胞和瘤病毒的初步发现.

主要成果:

MPNSTs表现出与巨细胞和不同的T细胞透的免疫背景,表明免疫治疗的潜力.
使用巨细胞向策略和结性病毒的初步研究显示出有希望.
识别对免疫疗法有反应的患者子集是关键的下一步.

结论:

MPNSTs的免疫微环境提供了治疗机会.
新兴的基于免疫的策略,包括向巨细胞和使用型病毒,需要进一步调查.
对MPNST患者进行个性化免疫治疗,生物标志物的发现至关重要.

关键词:

生物标志物生物标志物免疫检查点抑制剂免疫检查点抑制剂免疫抑制是一种免疫抑制.免疫疗法免疫疗法针对巨细胞的向.恶性外围神经罩瘤这是神经纤维素瘤.瘤性病毒疗法瘤性病毒疗法软组织肉瘤软组织肉瘤瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...